Alnylam drug approval marks watershed moment for gene-silencing field

Alnylam is one of several local biotechs developing drugs based on Nobel Prize-winning technology known as RNA interference.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.